Authors’ contributions {31b}
CM
TS is the chief investigator and lead trial methodologist who conceived the study and led the protocol development. AS is the clinical lead for the study; he provided clinical input into all aspects of the study. AS, CM, and TS drafted the manuscript. All members of the steering committee contributed to revisions of the manuscript and approved the final manuscript.